# Immunophenotyping From Blood of Patients With Malignant Gliomas

> **NCT02022384** · — · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 50 (estimated)

## Conditions studied

- Anaplastic Astrocytoma
- Glioblastoma Multiforme

## Interventions

- **OTHER:** Blood sample and life quality questionnaires

## Key facts

- **NCT ID:** NCT02022384
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022384, "Immunophenotyping From Blood of Patients With Malignant Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02022384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*